JAJoão Pedro Ignotti de Almeida

João Pedro Ignotti de Almeida

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


João Pedro Ignotti de Almeida has a total of 8 co-authors. Here are the top co-authors by number of shared publications:

  • Caio Pereira Mueller

    Universidade Federal do Paraná Curitiba PR Brasil Universidade Federal do Paraná, Curitiba, PR, Brasil

    2 shared publications
  • Cléo Otaviano Mesa Júnior

    Universidade Federal do Paraná Departamento de Medicina Interna Serviço de Endocrinologia e Metabologia (SEMPR) Curitiba PR Brasil Departamento de Medicina Interna, Serviço de Endocrinologia e Metabologia (SEMPR), Universidade Federal do Paraná, Curitiba, PR, Brasil

    2 shared publications
  • Fabíola Yukiko Miasaki

    Universidade Federal do Paraná Departamento de Medicina Interna Serviço de Endocrinologia e Metabologia (SEMPR) Curitiba PR Brasil Departamento de Medicina Interna, Serviço de Endocrinologia e Metabologia (SEMPR), Universidade Federal do Paraná, Curitiba, PR, Brasil

    2 shared publications
  • Gisah Amaral de Carvalho

    Universidade Federal do Paraná Departamento de Medicina Interna Serviço de Endocrinologia e Metabologia (SEMPR) Curitiba PR Brasil Departamento de Medicina Interna, Serviço de Endocrinologia e Metabologia (SEMPR), Universidade Federal do Paraná, Curitiba, PR, Brasil

    2 shared publications
  • Hans Graf

    Universidade Federal do Paraná Departamento de Medicina Interna Serviço de Endocrinologia e Metabologia (SEMPR) Curitiba PR Brasil Departamento de Medicina Interna, Serviço de Endocrinologia e Metabologia (SEMPR), Universidade Federal do Paraná, Curitiba, PR, Brasil

    2 shared publications
  • Isabela Busto Silva

    Universidade Federal do Paraná Departamento de Medicina Interna Serviço de Endocrinologia e Metabologia (SEMPR) Curitiba PR Brasil Departamento de Medicina Interna, Serviço de Endocrinologia e Metabologia (SEMPR), Universidade Federal do Paraná, Curitiba, PR, Brasil

    2 shared publications

Latest Publications

  • Remission and relapse rates in Graves’ disease treated with methimazole: a 20-year retrospective cohort study

    by Isabela Busto Silva, Gisah Amaral de Carvalho, Fabíola Yukiko Miasaki, João Pedro Ignotti de Almeida, Matheus Pessini Sousa, Caio Pereira Mueller, Hans Graf, Mariana Driesel Bertolin, Cléo Otaviano Mesa Júnior

    Objective: To evaluate remission and relapse rates in patients with Graves’ disease treated with methimazole and to identify clinical and laboratory predictors of these outcomes. Subjects and methods: We conducted a retrospective cohort study of 425 adult patients newly diagnosed with Graves’ disease at a single tertiary center between 2002 and 2022. All patients received methimazole for at least 12 months. Remission was defined as drug-free biochemical euthyroidism for 12 months or longer after therapy withdrawal. Univariate and multivariate [...] ABSTRACT Objective: To evaluate remission and relapse rates in patients with Graves’ disease treated with methimazole and to identify clinical and laboratory predictors of these outcomes. Subjects and methods: We conducted a retrospective cohort study of 425 adult patients newly diagnosed with Graves’ disease at a single tertiary center between 2002 and 2022. All patients received methimazole for at least 12 months. Remission was defined as drug-free biochemical euthyroidism for 12 months or longer after therapy withdrawal. Univariate and multivariate

  • Open Access

    The decline of iodine therapy in the treatment of Graves’ disease in a hospital center: a 20-year analysis

    by Isabela Busto Silva, Gisah Amaral de Carvalho, Fabíola Yukiko Miasaki, João Pedro Ignotti de Almeida, Matheus Pessini Sousa, Caio Pereira Mueller, Hans Graf, Mariana Driesel Bertolin, Cléo Otaviano Mesa Júnior

    Objective: To evaluate and describe the changes in the therapeutic approach to Graves’ disease at a tertiary hospital center over a 20-year period, with an emphasis on the frequency of prescription and the timing of radioactive iodine indication. Subjects and methods: We conducted a retrospective analysis of data from medical records of patients recently diagnosed with Graves’ disease (GD) and followed up at a single institution during two consecutive periods: Group A diagnosed between 2002 and 2010, and Group [...] ABSTRACT Objective: To evaluate and describe the changes in the therapeutic approach to Graves’ disease at a tertiary hospital center over a 20-year period, with an emphasis on the frequency of prescription and the timing of radioactive iodine indication. Subjects and methods: We conducted a retrospective analysis of data from medical records of patients recently diagnosed with Graves’ disease (GD) and followed up at a single institution during two consecutive periods: Group A diagnosed between 2002 and 2010, and Group